Skip to main content

September 2022

 

 

academics

 

Clinical research courses

Job for Pharmacists (13 posts) at District Health Society

NHM is being implemented in the district under the District Health Society, Jamnagar.  Which mainly includes Maternal Welfare, Family Welfare and Adolescent Health etc. For the implementation of the programme, the District Health Sasapati has to fill up the following posts and for the posts created/vacant in the future - waiting list should be prepared. 

Post : Pharmacist cum Data Asst (RBSK)

NIBMG Doctoral Degree in Pharma Job | Salary upto Rs. 78,000 pm

National Institute of Biomedical Genomics (NIBMG) Kalyani is an Institute of Government of India, Ministry of Science & Technology, Department of Biotechnology. The Institute has created necessary physical infrastructure and critical platform technologies to support research, translation, and training in biomedical genomics.

Post : Project Scientist, Senior Project Associate

Job for B.Pharm as PPC Junior Executive at KAPL - Government of India Enterprise

Karnataka Antibiotics and Pharmaceuticals Limited, KAPL Bengaluru is a Government of India Enterprise. Karnataka Antibiotics and Pharmaceuticals Limited is a Joint Sector Company of Government of India with shareholding from Government of Karnataka through Karnataka State Industrial Infrastructure Development Corporation KSIIDC. From a modest beginning in 1984, KAPL has grown exponentially in the areas of manufacturing and marketing of various life saving and essential drugs.

Reusable contact lenses more than triple risk of rare preventable eye infection

People who wear reusable contact lenses are nearly four times as likely as those wearing daily disposables to develop a rare sight-threatening eye infection, finds a study led by UCL and Moorfields researchers.

Uncovering the skin’s secrets : Studies show how skin forms differently across the body

Two new UC Davis Health studies explored how differences in skin composition may lead to dermatological conditions, such as psoriasis and atopic dermatitis.

“Skin does not have a uniform composition throughout the body,” said Emanual Maverakis, professor of dermatology, molecular medical microbiology at UC Davis and senior author on both studies. “Different skin characteristics at different body sites may affect the skin’s susceptibility to certain diseases.”

New mechanism extends life of immune system

A new mechanism that slows down and may even prevent the natural ageing of immune cells – one of the nine hallmarks of ageing – has been identified by an international team led by UCL scientists.

Published in Nature Cell Biology, researchers say the discovery in-vitro (cells) and validated in mice was ‘unexpected’ and believe harnessing the mechanism could extend the life of the immune system, allowing people to live healthier and longer, and would also have clinical utility for diseases such as cancer and dementia.

Applications are invited for the post of Assistant Professor at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Consultant / Assistant Professor (Non- Medical)

Government constitute Committee on affordable medicines and health products

Government constitutes a committee on affordable medicines and health products to address the issues of pharma industries giving temptation for prescribing medicines.

The committee is chaired by Niti ayog and contains five members which includes, Chief Economic Adviser, Ministry of Finance; Secretary, Department of Health Research; Vice-Chairperson, NLEM Joint; Secretary, Department of Industrial Policy & Promotion; and Director General of Health Services, Ministry of Health & Family Welfare.

EMA Recommends Granting a Conditional Marketing Authorisation for Loncastuximab Tesirine

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a conditional marketing authorisation for the medicinal product loncastuximab tesirine (Zynlonta), intended for the treatment of adult patients with diffuse large B-cell lymphoma and high-grade B-cell lymphoma.

The applicant for this medicinal product is ADC Therapeutics (NL) B.V.

Common mutation linked to COVID mortality

it may be the most baffling quirk of COVID: What manifests as minor, flu-like symptoms in some individuals spirals into severe disease, disability, or even death in others. A new paper published in Nature may explain the genetic underpinnings of this dichotomy.